REVIEW
Accepted on 31 Mar 2025
Targeting BCL2 in Waldenström Macroglobulinemia: From biology to treatment management
doi 10.3389/fonc.2025.1564869
- 137 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- BCL-2 Family Inhibitors in Hematologic Malignancies
BCL-2 Family Inhibitors in Hematologic Malignancies
2,446
Total downloads
9,050
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
MINI REVIEW
Published on 21 Mar 2025
The potential role of BCL-2 inhibition in amyloidosis and plasma cell leukemia
doi 10.3389/fonc.2025.1549891
- 922 views
REVIEW
Published on 21 Jan 2025
BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies
doi 10.3389/fonc.2024.1501950
- 1,181 views
ORIGINAL RESEARCH
Published on 09 Dec 2024
Efficacy and safety of hypomethylating agents in the treatment of AML/MDS patients relapsed post allogenetic hematopoietic stem cell transplantation
doi 10.3389/fonc.2024.1465334
- 704 views
MINI REVIEW
Published on 04 Nov 2024
Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma
doi 10.3389/fonc.2024.1490202
- 1,694 views
BRIEF RESEARCH REPORT
Published on 08 Apr 2024
Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity
doi 10.3389/fonc.2024.1394393
- 1,325 views
- 1 citation
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.